Stock Report

All about this stock under one free report Last Updated: 30-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Lactose (India) Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 524202

₹105.05

up-down-arrow ₹-1.05 (-0.99%)

As on 28-Aug-2026IST

Market cap

info icon

₹132 Cr

Revenue (TTM)

info icon

₹171 Cr

P/E Ratio

info icon

19.1

P/B Ratio

info icon

2

Div. Yield

info icon

0 %

Edit peer-selector-edit
Lactose (India) Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Market cap (₹ Cr)
 132 32,104 29,892 29,103 26,871
Revenue (₹ Cr)
 171 3,564 1,936 9,205 1,462
Net Profit (₹ Cr)
 6.93 414.00 288.22 -371.81 387.35
Net Margin (%)
 4.02 11.23 14.79 -3.93 26.01
RoE (%)
 10.89 8.38 29.77 -3.85 25.18
Price to Earnings
 19.09 78.49 103.71 -- 69.57
Price-To-Book
 1.97 6.38 22.27 3.64 15.55

Income Statement (₹ Cr)

Lactose (India) Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Operating Revenue arrow
170.68 3,564.00 1,935.80 9,205.28 1,461.80
Total Income arrow
172.46 3,686.00 1,948.58 9,449.59 1,489.25
Total Expenditure arrow
151.26 2,792.00 1,485.56 8,195.15 919.25
EBITDA arrow
19.42 772.00 450.24 1,010.13 542.56
Depreciation arrow
6.01 226.00 50.83 857.51 37.68
EBIT arrow
13.41 546.00 399.41 152.62 504.88
Interest arrow
5.63 217.00 40.84 342.73 3.77
Other Income arrow
1.78 122.00 12.78 244.31 27.45
Exceptional Items arrow
0.00 12.00 0.00 -216.88 0.00
Profit before Tax arrow
9.56 463.00 371.35 -162.68 528.56
Provision for Tax arrow
2.64 49.00 83.14 209.13 141.21
Profit after Tax arrow
6.93 414.00 288.22 -371.81 387.35

Liabilities (₹ Cr)

Lactose (India) Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Shareholder's Funds arrow
64.79 4,940.00 1,288.82 8,162.62 1,653.56
Minority Interest arrow
0.00 -5.00 0.00 0.00 -1.13
Non-Current Liabilities arrow
28.64 1,712.00 202.03 5,044.14 42.40
Current Liabilities arrow
89.80 1,622.00 835.87 4,758.28 230.82
Total Liabilities arrow
133.47 8,100.00 1,451.43 15,513.53 1,549.26

Assets (₹ Cr)

Lactose (India) Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Non-Current Assets arrow
68.58 5,343.00 519.60 10,211.52 1,026.85
Current Assets arrow
98.62 2,606.00 1,681.81 7,191.66 881.27
Total Assets arrow
133.47 8,100.00 1,451.43 15,513.53 1,549.26
Total Debt* arrow
56.22 1,859.00 393.17 4,720.27 8.18
Net Current Assets arrow
8.82 984.00 845.94 2,433.38 650.46
Contingent Liabilities arrow
7.80 770.26 12.25 99.76 15.38

Cashflow (₹ Cr)

Lactose (India) Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Cash From Operating Activities arrow
-0.29 -22.00 159.18 892.30 118.34
Cash Flow from Investing Activities arrow
-15.57 -783.00 -64.81 -477.46 -223.94
Cash from Financing Activities arrow
18.81 409.00 -39.81 -440.83 261.12
Net Cash Inflow / Outflow arrow
2.95 -396.00 54.56 -25.99 155.52

Ratios

Profitability Ratios

 Lactose (India) Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
ROCE (%) arrow
13.01 4.07 26.97 6.61 20.14
ROE (%) arrow
10.89 8.38 29.77 -3.85 25.18
ROA (%) arrow
4.38 4.94 24.77 -2.21 21.93
EBIT Margin (%) arrow
7.86 15.32 20.63 1.66 34.54
Net Margin (%) arrow
4.02 11.23 14.79 -3.93 26.01
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Lactose (India) Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Revenue Growth (%) arrow
34.91 18.37 46.65 0.78 40.90
EBIT Growth (%) arrow
28.97 252.26 62.13 -70.53 124.50
Net Profit Growth (%) arrow
57.67 377.85 89.49 -1,383.43 104.15
EPS Growth (%) arrow
57.67 1,001.33 78.60 -484.84 42.32
Book Value Growth (%) arrow
10.86 29.77 42.49 2.28 94.96

Valuation Ratios

 Lactose (India) Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Price / Earnings arrow
19.09 80.56 102.12 -93.01 69.57
Price / Book Value arrow
1.97 6.38 22.27 3.64 15.55
Dividend Yield (%) arrow
0.00 0.00 0.08 0.00 0.08
EV/EBITDA arrow
9.45 43.48 66.20 32.91 49.08
Market Cap (₹ Cr) arrow
111.66 23,064.69 0.00 29,731.27 19,988.69

Solvency Ratios

 Lactose (India) Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Debt to Equity arrow
0.35 0.31 0.11 0.53 0.01
Short term debt to equity ratio arrow
0.40 0.11 0.54 0.12 0.02
Current Ratio arrow
1.10 1.61 2.01 1.51 3.82
Quick Ratio arrow
0.48 1.06 1.14 0.87 2.82
Interest Coverage arrow
2.70 3.13 10.09 0.53 141.16

Operating Efficiency Ratios

 Lactose (India) Wockhardt Rubicon Research Piramal Pharma Acutaas Chemicals
Debtors to sales (%) arrow
19.60 16.50 26.28 23.44 24.80
Asset Turnover arrow
1.08 0.43 1.66 0.55 0.83
Receivable days arrow
58.07 60.36 47.59 77.05 90.06
Inventory Days arrow
64.83 64.42 62.58 77.13 61.02
Payable days arrow
67.48 218.94 228.78 173.49 96.06
Cash Conversion Cycle arrow
55.42 -94.15 -118.62 -19.30 55.02
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...